MedTrace Logo

Investigating the Relation Between Environmental Factors and Activity-participation in Children With Cerebral Palsy

NCT03640611 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 306

Last updated 2020-07-29

No results posted yet for this study

Summary

Cerebral palsy (CP) is a chronic condition that causes the most childhood disabilities on worldwide. Impairment in movement and posture development seen in children with CP it causes difficulties in performing activities and affect in emotional, social, and cognitive abilities cause limited participation in everyday life. The ICF-CY child is divided into five categories: body structure and functions, activities, participation, environmental and personal factors, it is treated holistically. Initially, children with CP have adopted the view that environmental factors can also affect functionality, while focusing on the treatment of motor disorders to reduce activity and participation limitations in physiotherapy and rehabilitation applications. Environmental factors; the environment in which the child lives, his family, the devices he uses, health and care services, and government policies. These factors vary according to each country's own cultural and economic opportunities. The investigator planned to do this study because we found that there is a need for a comprehensive study of children with SP in Turkey, which does not reveal the relationship between environmental factors and activity and level of participation.

Conditions

  • Cerebral Palsy
  • Activity
  • Participation

Sponsors & Collaborators

  • Hacettepe University

    lead OTHER

Principal Investigators

  • ÖZGE ÇANKAYA · Hacettepe University

Eligibility

Min Age
2 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-15
Primary Completion
2019-05-01
Completion
2019-08-26

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03640611 on ClinicalTrials.gov